Who is sponsoring NCT04192838?

NCT04192838 is sponsored by Salvador Peiro.

What drugs are being tested in NCT04192838?

Interventions in NCT04192838: Laparoscopic incisional ventral hernia repair, Open incisional ventral hernia repair.

What condition does NCT04192838 study?

NCT04192838 studies Incisional Hernia.

Is NCT04192838 still recruiting?

NCT04192838 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04192838

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Incisional Hernia Repair Long-term Outcomes

Completed NA Last updated 5 February 2020

What this trial tests

NA trial testing Laparoscopic incisional ventral hernia repair in Incisional Hernia in 86 participants. Completed in 31 January 2020.

Timeline

24 February 2003

Primary endpoint
24 December 2019

31 January 2020

Quick facts

Lead sponsor	Salvador Peiro
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	86
Start date	24 February 2003
Primary completion	24 December 2019
Estimated completion	31 January 2020
Sites	3 locations across Spain

Drugs / interventions tested

Laparoscopic incisional ventral hernia repair
Open incisional ventral hernia repair

Conditions studied

Incisional Hernia — all drugs for Incisional Hernia →

Sponsor

Salvador Peiro

Who can join

18 and older, any sex, with Incisional Hernia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Long-term extension of a previous trial comparing outcomes after open (OVHR) or laparoscopic incisional ventral hernia repair (LVHR), assessing recurrence, reoperation, intraperitoneal mesh-related complications and self-reported quality-of-life with 10-15 years of follow-up.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Laparoscopic Versus Open Incisional Hernia Repair: Long-Term Follow-up Results of a Randomized Clinical Trial.
Asencio F, Carbó J, Ferri R, Peiró S, et al · · 2021 · cited 17× · PMID 34018042 · DOI 10.1007/s00268-021-06164-7

Verify or expand the search:

Other recruiting trials for Incisional Hernia

Currently open trials in the same condition.

NCT06762561 — Prophylactic Mesh Reinforcement After Open Aortic Aneurysm Repair · recruiting
NCT06499324 — Surgery with Botulinum Toxin a for Incisional Hernia · Phase 3 · recruiting
NCT06220058 — Comparing Polypropylene Mesh and "Small Bites" Technique in Emergency Colorectal Surgery's Midline Laparotomy Closure. S · NA · recruiting
NCT05596357 — Incisional heRnia dIgestion Sexuality · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04192838 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Salvador Peiro
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04192838.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing